Researchers at Southern Medical University have identified that Bifidobacterium animalis, a common probiotic, secretes mannose to boost the effectiveness of melanoma immunotherapy. According to a study published in the May 2026 issue of Cancer Biology & Medicine, this sugar activates CD8⁺ T cells by targeting the Hippo-YAP1 signaling pathway, offering a potential new strategy to overcome resistance to anti-PD-1 therapies.
How does Bifidobacterium animalis influence cancer treatment?
The bacterium works by producing mannose, a metabolite that acts as a signal for the immune system. According to the research team at Southern Medical University, B. animalis does not need to colonize tumor tissue to be effective. Instead, it secretes metabolites that travel through the body to enhance the anti-tumor response. In mouse models with B16-F10 melanoma, oral administration of the probiotic significantly reduced both tumor volume and weight.
Researchers discovered that mannose acts as a “molecular key” that enters CD8⁺ T cells via glucose transporter 1 (GLUT1), effectively removing a “brake” on the immune system that otherwise prevents T cells from attacking cancer cells.
What is the Hippo-YAP1 pathway’s role in immunity?
The Hippo-YAP1 pathway serves as a critical regulator of T-cell function. The study explains that the transcription factor YAP1 normally suppresses T-cell effector function. When mannose is introduced, it triggers the phosphorylation of YAP1, trapping it in the cytoplasm and preventing it from entering the nucleus. This action restores the T cell’s ability to produce cytotoxic molecules, including granzyme B (GZMB), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α).
Can mannose supplementation replace probiotics?
Data from the study suggests that oral mannose supplementation may be a viable alternative to live probiotic therapy. Researchers found that mice drinking water supplemented with 1% mannose experienced similar anti-tumor benefits as those given the live B. animalis bacteria. The findings were supported by the National Natural Science Foundation of China and the Guangzhou Science and Technology Project.
Comparison: Probiotic vs. Metabolite Therapy
| Method | Primary Mechanism | Key Benefit |
|---|---|---|
| B. animalis (Probiotic) | Metabolite secretion | Enriches beneficial gut microbiome |
| Mannose (Sugar) | Direct Hippo-YAP1 inhibition | Standardized, easy to dose |
The study notes a synergistic effect when combining B. animalis with anti-PD-1 therapy. Patients who currently show resistance to checkpoint inhibitors may benefit from future protocols that integrate these metabolic interventions.
Frequently Asked Questions
Why do some melanoma patients fail to respond to immunotherapy?
More than half of patients do not respond or develop resistance, often due to the tumor microenvironment or gut microbiome, according to the researchers.
Is Bifidobacterium animalis safe for human use?
Yes, B. animalis is a widely consumed probiotic found in fermented dairy products and has an established safety record.
Does the bacterium have to reach the tumor to work?
No. The research indicates that the beneficial effects are mediated entirely through secreted metabolites, meaning the bacteria do not need to colonize the tumor tissue itself.
Have you or a loved one navigated the complexities of melanoma treatment? Share your experiences in the comments below or subscribe to our medical research newsletter for the latest updates on immunotherapy breakthroughs.
